At Johnson & Johnson Innovation, they seek to collaborate with early-stage companies and researchers to generate transformational healthcare solutions that can bring value to patients.
Given the travel and safety regulations in place to combat the coronavirus COVID-19 pandemic, the Johnson & Johnson Innovation team will host on 29-30 September a virtual scientific and partnering event on state-of-the-art developments in immunology, bringing together entrepreneurs, start-ups, researchers, and scientists from across Europe and beyond.
The event will include:
- a keynote on their latest innovations in immunology
- a panel discussion with European thought leaders in the field
- a briefing on the Johnson & Johnson Innovation model for supporting scientists and entrepreneurs
- one-to-one partnering meetings between the Johnson & Johnson Innovation team and selected companies, researchers or other organizations
Registrations for the actual event will be accepted until the event kick-off on 29 September at 15:00 CEST. The meeting application form will remain open until 16 October.